|
|
||||||||



* Department of Hematology and Oncology, Graduate School of Medicine, and
Department of Pathology, Faculty of Medicine, University of Tokyo, Tokyo, Japan;
Growth Factor Division, National Cancer Center Research Institute, Tokyo, Japan; and
Department of Hematology, Dokkyo University School of Medicine, Tochigi, Japan
The lymphocyte-specific Cas family protein Cas-L (Crk-associated substrate lymphocyte type) has been implicated to function in lymphocyte movement, mediated mainly by integrin signaling. However, its physiological role is poorly understood. In this study we analyzed the function of Cas-L in lymphocytes using gene-targeted mice. The mutant mice showed a deficit of marginal zone B (MZB) cells and a decrease of cell number in secondary lymphoid organs. An insufficient chemotactic response and perturbed cell adhesion were observed in Cas-L-deficient lymphocytes, suggesting that the aberrant localization was responsible for the deficit of MZB cells. Moreover, we found that lymphocyte trafficking was altered in Cas-L-deficient mice, which gave a potential reason for contraction of secondary lymphoid tissues. Thus, Cas-L affects homeostasis of MZB cells and peripheral lymphoid organs, which is considered to be relevant to impaired lymphocyte migration and adhesion.
This article has been cited by other articles:
![]() |
E. Izumchenko, M. K. Singh, O. V. Plotnikova, N. Tikhmyanova, J. L. Little, I. G. Serebriiskii, S. Seo, M. Kurokawa, B. L. Egleston, A. Klein-Szanto, et al. NEDD9 Promotes Oncogenic Signaling in Mammary Tumor Development Cancer Res., September 15, 2009; 69(18): 7198 - 7206. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. O'Neill, S. Seo, I. G. Serebriiskii, S. R. Lessin, and E. A. Golemis A New Central Scaffold for Metastasis: Parsing HEF1/Cas-L/NEDD9 Cancer Res., October 1, 2007; 67(19): 8975 - 8979. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |